No sisyphean task: how the FDA can regulate electronic cigarettes.
1Seton Hall University School of Law, USA. jordan.paradise@shu.edu
Electronic cigarettes (e-cigarettes) offer nicotine delivery without traditional tobacco's carcinogens, but their public health impact and regulatory status remain unclear. This article examines e-cigarette regulation under the Family Smoking Prevention and Tobacco Control Act of 2009.
Area of Science:
- Public Health
- Regulatory Science
- Tobacco Control
Background:
- The proliferation of electronic cigarettes (e-cigarettes) presents a significant challenge to public health due to their unknown long-term effects.
- E-cigarettes are marketed as safer alternatives for smoking cessation and reduction, appealing to a wide consumer base, including youth.
- Existing regulatory frameworks struggle to address the novel nicotine delivery systems and marketing claims associated with e-cigarettes.
Purpose of the Study:
- To investigate the regulatory challenges posed by e-cigarettes in the context of the Family Smoking Prevention and Tobacco Control Act of 2009 (TCA).
- To examine the history of tobacco regulation and its implications for e-cigarette oversight.
- To propose a strengthened regulatory approach for e-cigarettes within the current statutory framework.
Main Methods:
- Analysis of the Family Smoking Prevention and Tobacco Control Act of 2009 (TCA).
- Review of historical congressional actions concerning tobacco regulation.
- Examination of case law impacting the Food and Drug Administration's (FDA) enforcement capabilities.
- Assessment of e-cigarette characteristics, consumer use, and marketing claims.
Main Results:
- E-cigarettes present unique regulatory hurdles due to their novel nicotine delivery and lack of safety data.
- Recent legal decisions have complicated the FDA's authority over e-cigarettes, blurring lines between tobacco products, drugs, and medical devices.
- The current regulatory landscape, influenced by the TCA, requires strategic adaptation to effectively manage e-cigarette risks.
Conclusions:
- Strengthening e-cigarette regulation requires increased scrutiny of manufacturer claims that could trigger drug or medical device provisions.
- Leveraging provisions for new tobacco products and modified risk tobacco products is crucial.
- Promulgating specific FDA regulations and guidance for e-cigarettes is essential for effective public health protection.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Drug Regulation
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Control Governance: Regulatory Bodies and Their Impact
FDA Approved Drugs: Changes to Approved Drugs
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
